4 MANAGEMENT

 

MANAGEMENT CONTRACTS AND RULES REGARDING OUTSIDE MANDATES

No agreements between the Company and third parties that are not part of the Tecan Group were entered into or renewed in the year under review for the purpose of delegating management responsibilities.

According to the Articles of Incorporation, the permitted number of other mandates of the members of the Management Board in the highest executive management or bodies of legal entities outside of the Company’s group is limited to two mandates in listed and four mandates in non-listed companies, foundations and other legal entities with economic purpose. Mandates in different legal entities of the same group (including in joint ventures directly or indirectly owned by such a group or the Company that are not consolidated) are counted as one mandate per group, but may not exceed the number of 20 additional mandates if counted separately. Mandates held by members of the Management Board by order of the Company shall not be subject to the limitations set out above.

1 MONICA MONOTAS

Chief Executive Officer (CEO)

Member since joining Tecan in August, 2025


1973
US and Colombian citizen
Industrial engineering degree (Universidad del Norte, Colombia) and MBA in finance (University of Rochester, USA)
 

Professional background:
Held various roles at Thermo Fisher Scientific, Inc. from 1999 to 2023, with assignments in France, Spain, Switzerland, and the USA. Positions included Vice President and General Manager, Life Sciences and Laboratory Products Group; President Europe, Customer Channels Group Growth, Protection and Separation Products Group; and most recently Senior Vice President and President. Previously, Financial Analyst, Americas Customer Operations /Integrated Supply Chain at Xerox Corporation, Rochester, NY, USA (1997–1998), and consultant at Marun & Frias Management Consultants, Barranquilla, Colombia (1995–1996).

Other activities:
none

 

2 TANIA MICKI

Chief Financial Officer (CFO) (until end of May 2026)

Member since 2020 
Joining Tecan in 2020


1971
French and Swiss citizen MBA General Management (INSEAD, Fontainebleau, France), graduated ESCP (École Supérieure de Commerce de Paris) in Paris, France with major Finance/ Audit/Accounting, Master's degree in Russian (University Paris Nanterre, France)

Professional background:
1996 to 2006 various financial positions at General Mills; 2006 to 2009 Vice President Finance, Planning and Analysis Europe, Gate Group; 2009 to 2010 Seed Supply Finance Lead EMEA, Monsanto; 2010 to 2020 variety of positions at Sulzer AG, most recently as Chief Risk Officer and Group Internal Audit Head, other positions included CFO Global Markets in a group-wide function

Other activities: 
ASM International1, Member of the Board;

3 MUKTA ACHARYA

Executive Vice President Head of the Life Sciences Business division

Member since August 2024
Joining Tecan in 2022


1984
US citizen Master’s degree Engineering Management (Dartmouth College, USA), Bachelor’s degree in Mechanical Engineering (Osmania University, Hyderabad, India)

Professional background:
2008 to 2010 Senior Management Consultant at Kaiser Associates, driving strategy and revenue impact across pharma, healthcare, technology, and consumer foods industries; 2010 to 2018 at CVS Health, held various leadership roles, including Director of Enterprise Product Innovation & Management (2016 to 2018), overseeing product development, business models, M&A, and strategic growth; 2018 to 2022 at Thermo Fisher Scientific, served as VP & GM of Single-Use Flexible Consumables, leading Product Management, R&D, Sales, and Operations while holding multiple P&L leadership roles across markets; since 2022, President, Tecan Americas at Tecan Group, overseeing financial and market performance of the Life Sciences Business division

Other activities:
None

4 ULRICH KANTER

Executive Vice President Global Head of Operations & IT

Member since 2014
Joining Tecan in 2014 


1963
German citizen
Mechanical Engineer
(Berufsakademie Mannheim, Germany) and Diploma in Business Administration (Verwaltungs- und Wirtschaftsakademie at the J.W. Goethe University Frankfurt, Germany)

Professional background: 
1995 to 2000 Vice President, Operations and Global Supply
Chain Manager at AVL Medizintechnik (acquired by Roche Diagnostics in 2000); 2000 to 2014 diverse positions with increasing management responsibility at Roche Diagnostics, most recently as General Manager and Head of Research & Development in Graz, Austria

Other activities: 
Toolpoint for Lab Science2, Member of the Board

5 ERIK NORSTRÖM

Executive Vice President Head of Corporate Development

Member since 2017
Joining Tecan in 2017


1973
Swedish and Swiss citizen
M.Sc. in Chemical Engineering (Chalmers University of Technology, Göteborg, Sweden), B.Sc. in
Business Administration (Göteborg University of Economics and Commercial Law, Sweden)

Professional background:
2001 to 2008 Corporate Development Director at F. Hoffmann-La Roche AG, Basel; 2008 to 2012 Head of M&A and
alliances at Nobel Biocare AG, Zürich; 2012 to 2015 Head of Corporate Development and M&A, Member of the Corporate Leadership Team at Nobel Biocare AG, Zürich; 2015 to 2017 Corporate Vice President strategic development and M&A, Member of the Corporate Leadership team at Chr. Hansen a/s, Copenhagen, Denmark

Other activities:
None

6  INGRID PÜRGSTALLER

Chief People Officer (CPO)

Member since 2020
Joining Tecan in 2011


7 ANDREAS WILHELM

Executive Vice President General Counsel and Secretary of the Board of Directors of Tecan Group Ltd.

Member since 2012
Joining Tecan in 2004


8 DR. WAEL YARED

Executive Vice President Chief Technology Officer (CTO) Head Research and Development (until end of January 2026)

Member since 2019
Joining Tecan in 2019


  1. Public company
  2. Private company

MEMBERS WHO LEFT TECAN


DR. ACHIM VON LEOPRECHTING

until August 2025

RALF GRIEBEL

until September 2025